PL1934248T3 - Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznych - Google Patents

Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznych

Info

Publication number
PL1934248T3
PL1934248T3 PL06806112T PL06806112T PL1934248T3 PL 1934248 T3 PL1934248 T3 PL 1934248T3 PL 06806112 T PL06806112 T PL 06806112T PL 06806112 T PL06806112 T PL 06806112T PL 1934248 T3 PL1934248 T3 PL 1934248T3
Authority
PL
Poland
Prior art keywords
alfavbeta3
therapeutic
selective
diagnostic applications
peptide antagonist
Prior art date
Application number
PL06806112T
Other languages
English (en)
Inventor
Gatto Annarita Del
Laura Zaccaro
Carlo Pedone
Michele Saviano
Original Assignee
Advanced Accelerator Applications
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Accelerator Applications filed Critical Advanced Accelerator Applications
Publication of PL1934248T3 publication Critical patent/PL1934248T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL06806112T 2005-10-12 2006-10-09 Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznych PL1934248T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72529405P 2005-10-12 2005-10-12
EP06806112.6A EP1934248B1 (en) 2005-10-12 2006-10-09 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications
PCT/EP2006/009733 WO2007042241A2 (en) 2005-10-12 2006-10-09 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications

Publications (1)

Publication Number Publication Date
PL1934248T3 true PL1934248T3 (pl) 2013-09-30

Family

ID=37943159

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06806112T PL1934248T3 (pl) 2005-10-12 2006-10-09 Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznych

Country Status (7)

Country Link
US (2) US8546526B2 (pl)
EP (1) EP1934248B1 (pl)
JP (1) JP5221355B2 (pl)
CA (1) CA2625436C (pl)
ES (1) ES2413056T3 (pl)
PL (1) PL1934248T3 (pl)
WO (1) WO2007042241A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1934248T3 (pl) * 2005-10-12 2013-09-30 Advanced Accelerator Applications Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznych
US9775803B2 (en) 2011-10-19 2017-10-03 Samsung Electronics Co., Ltd. Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof
MA40998A (fr) 2014-11-21 2017-09-26 Ophirex Inc Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653036A1 (de) * 1996-12-19 1998-06-25 Merck Patent Gmbh Cyclopeptidderivate
PL1934248T3 (pl) * 2005-10-12 2013-09-30 Advanced Accelerator Applications Selektywne peptydowe związki antagonistyczne receptora alfavbeta3 do zastosowań leczniczych i diagnostycznych

Also Published As

Publication number Publication date
CA2625436A1 (en) 2007-04-19
US20080213190A1 (en) 2008-09-04
US9309288B2 (en) 2016-04-12
CA2625436C (en) 2016-01-05
EP1934248A2 (en) 2008-06-25
WO2007042241A3 (en) 2007-11-29
WO2007042241A2 (en) 2007-04-19
US20140094412A1 (en) 2014-04-03
EP1934248B1 (en) 2013-05-01
US8546526B2 (en) 2013-10-01
ES2413056T3 (es) 2013-07-15
JP2009512643A (ja) 2009-03-26
JP5221355B2 (ja) 2013-06-26

Similar Documents

Publication Publication Date Title
PL1951661T3 (pl) Antagoniści receptora glukagonu, wytwarzanie i terapeutyczne zastosowania
EP2000483A4 (en) VEGF RECEPTOR FUSION PROTEIN AND APPLICATION THEREOF
EP2058304A4 (en) P2X4 RECEPTOR ANTAGONIST
IL186527A0 (en) Toxin peptide therapeutic agents
IL178254A0 (en) Receptor coupling agents and therapeutic uses thereof
ZA200907094B (en) Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
IL190219A0 (en) Compounds which have activity at m1 receptor and their uses in medicine
PL2137191T3 (pl) Antagoniści obwodowego receptora opioidowego i ich zastosowania
SI1951658T1 (sl) Antagonisti glukagonskega receptorja priprava interapevtska uporaba
IL198650A0 (en) Progesterone receptor antagonists
IL203898A0 (en) Cdca1 peptide and pharmaceutical agent comprising the same
HRP20150661T1 (en) Peripheral opioid receptor and antagonists and uses thereof
PL2420231T3 (pl) Antagoniści receptora angiotensyny II do leczenia chorób sercowo-naczyniowych u kotów
GB0722996D0 (en) Depsipeptides and their therapeutic use
GB0524428D0 (en) Medicinal use of receptor ligands
EP1874800A4 (en) DIAGNOSTIC AND THERAPEUTIC AGENTS
GB0515140D0 (en) Therapeutic device
EP1874302A4 (en) ANTAGONISTS OF ANGIOTENSIN II RECEPTORS
DK1808446T3 (da) IL-18-receptor-antagonist og farmaceutisk sammensætning indeholdende antagonisten
EP1889565A4 (en) MEDICAL DEVICE
IL193427A0 (en) Polypeptide antagonist
GB0526120D0 (en) Therapeutic peptides
GB0402129D0 (en) Therapeutic and diagnostic peptides
GB0525029D0 (en) Receptor Antagonist
EP1951914A4 (en) DIAGNOSTIC AND THERAPEUTIC METHODS AND AGENTS